Logo image of NGVT

INGEVITY CORP (NGVT) Stock Fundamental Analysis

NYSE:NGVT - New York Stock Exchange, Inc. - US45688C1071 - Common Stock - Currency: USD

46.31  +0.13 (+0.28%)

After market: 46.31 0 (0%)

Fundamental Rating

4

Overall NGVT gets a fundamental rating of 4 out of 10. We evaluated NGVT against 85 industry peers in the Chemicals industry. NGVT has an average financial health and profitability rating. NGVT scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year NGVT was profitable.
In the past year NGVT had a positive cash flow from operations.
In multiple years NGVT reported negative net income over the last 5 years.
Each year in the past 5 years NGVT had a positive operating cash flow.
NGVT Yearly Net Income VS EBIT VS OCF VS FCFNGVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

With a Return On Assets value of -17.21%, NGVT is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
NGVT has a Return On Equity of -150.81%. This is amonst the worse of the industry: NGVT underperforms 92.94% of its industry peers.
The Return On Invested Capital of NGVT (12.56%) is better than 92.94% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NGVT is above the industry average of 6.83%.
The 3 year average ROIC (10.65%) for NGVT is below the current ROIC(12.56%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -17.21%
ROE -150.81%
ROIC 12.56%
ROA(3y)-4.58%
ROA(5y)-0.24%
ROE(3y)-63.66%
ROE(5y)-29.04%
ROIC(3y)10.65%
ROIC(5y)10.84%
NGVT Yearly ROA, ROE, ROICNGVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

NGVT has a better Operating Margin (21.09%) than 88.24% of its industry peers.
In the last couple of years the Operating Margin of NGVT has declined.
With a decent Gross Margin value of 34.69%, NGVT is doing good in the industry, outperforming 69.41% of the companies in the same industry.
In the last couple of years the Gross Margin of NGVT has declined.
Industry RankSector Rank
OM 21.09%
PM (TTM) N/A
GM 34.69%
OM growth 3Y-6.17%
OM growth 5Y-4.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.27%
GM growth 5Y-2.81%
NGVT Yearly Profit, Operating, Gross MarginsNGVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NGVT is still creating some value.
Compared to 1 year ago, NGVT has more shares outstanding
NGVT has less shares outstanding than it did 5 years ago.
NGVT has a worse debt/assets ratio than last year.
NGVT Yearly Shares OutstandingNGVT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NGVT Yearly Total Debt VS Total AssetsNGVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.23 indicates that NGVT is not a great score, but indicates only limited risk for bankruptcy at the moment.
NGVT has a Altman-Z score (2.23) which is in line with its industry peers.
The Debt to FCF ratio of NGVT is 14.65, which is on the high side as it means it would take NGVT, 14.65 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 14.65, NGVT perfoms like the industry average, outperforming 58.82% of the companies in the same industry.
NGVT has a Debt/Equity ratio of 5.68. This is a high value indicating a heavy dependency on external financing.
NGVT has a worse Debt to Equity ratio (5.68) than 91.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.68
Debt/FCF 14.65
Altman-Z 2.23
ROIC/WACC1.43
WACC8.77%
NGVT Yearly LT Debt VS Equity VS FCFNGVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

NGVT has a Current Ratio of 2.00. This indicates that NGVT is financially healthy and has no problem in meeting its short term obligations.
NGVT has a Current ratio (2.00) which is in line with its industry peers.
A Quick Ratio of 1.08 indicates that NGVT should not have too much problems paying its short term obligations.
The Quick ratio of NGVT (1.08) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 1.08
NGVT Yearly Current Assets VS Current LiabilitesNGVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

NGVT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.90%, which is quite impressive.
The Earnings Per Share has been decreasing by -6.12% on average over the past years.
Looking at the last year, NGVT shows a very negative growth in Revenue. The Revenue has decreased by -17.64% in the last year.
The Revenue has been growing slightly by 1.70% on average over the past years.
EPS 1Y (TTM)20.9%
EPS 3Y-11.81%
EPS 5Y-6.12%
EPS Q2Q%90.38%
Revenue 1Y (TTM)-17.64%
Revenue growth 3Y0.36%
Revenue growth 5Y1.7%
Sales Q2Q%-16.5%

3.2 Future

NGVT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.18% yearly.
NGVT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.23% yearly.
EPS Next Y21.23%
EPS Next 2Y18.67%
EPS Next 3Y17.18%
EPS Next 5YN/A
Revenue Next Year-5.89%
Revenue Next 2Y-0.73%
Revenue Next 3Y1.23%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NGVT Yearly Revenue VS EstimatesNGVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
NGVT Yearly EPS VS EstimatesNGVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.43, the valuation of NGVT can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of NGVT indicates a rather cheap valuation: NGVT is cheaper than 85.88% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.53. NGVT is valued rather cheaply when compared to this.
NGVT is valuated reasonably with a Price/Forward Earnings ratio of 9.19.
Based on the Price/Forward Earnings ratio, NGVT is valued cheaper than 84.71% of the companies in the same industry.
NGVT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.71.
Industry RankSector Rank
PE 11.43
Fwd PE 9.19
NGVT Price Earnings VS Forward Price EarningsNGVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NGVT is valued a bit cheaper than 76.47% of the companies in the same industry.
NGVT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NGVT is cheaper than 74.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.75
EV/EBITDA 7.74
NGVT Per share dataNGVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NGVT's earnings are expected to grow with 17.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.54
PEG (5Y)N/A
EPS Next 2Y18.67%
EPS Next 3Y17.18%

0

5. Dividend

5.1 Amount

NGVT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INGEVITY CORP

NYSE:NGVT (7/22/2025, 8:04:00 PM)

After market: 46.31 0 (0%)

46.31

+0.13 (+0.28%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners103.19%
Inst Owner Change-0.08%
Ins Owners1.03%
Ins Owner Change24.4%
Market Cap1.69B
Analysts82
Price Target52.79 (13.99%)
Short Float %3.3%
Short Ratio4.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)117.25%
Min EPS beat(2)31.61%
Max EPS beat(2)202.89%
EPS beat(4)3
Avg EPS beat(4)62.07%
Min EPS beat(4)-6.05%
Max EPS beat(4)202.89%
EPS beat(8)6
Avg EPS beat(8)64.28%
EPS beat(12)8
Avg EPS beat(12)41.57%
EPS beat(16)11
Avg EPS beat(16)35.74%
Revenue beat(2)0
Avg Revenue beat(2)-4.11%
Min Revenue beat(2)-5.75%
Max Revenue beat(2)-2.47%
Revenue beat(4)0
Avg Revenue beat(4)-4.53%
Min Revenue beat(4)-6.04%
Max Revenue beat(4)-2.47%
Revenue beat(8)2
Avg Revenue beat(8)-1.58%
Revenue beat(12)4
Avg Revenue beat(12)-0.92%
Revenue beat(16)8
Avg Revenue beat(16)1.42%
PT rev (1m)0%
PT rev (3m)-11.54%
EPS NQ rev (1m)-0.64%
EPS NQ rev (3m)-9.18%
EPS NY rev (1m)0.12%
EPS NY rev (3m)-4.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.1%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)-2.72%
Valuation
Industry RankSector Rank
PE 11.43
Fwd PE 9.19
P/S 1.25
P/FCF 17.75
P/OCF 10.17
P/B 7.2
P/tB N/A
EV/EBITDA 7.74
EPS(TTM)4.05
EY8.75%
EPS(NY)5.04
Fwd EY10.89%
FCF(TTM)2.61
FCFY5.63%
OCF(TTM)4.56
OCFY9.84%
SpS37.04
BVpS6.43
TBVpS-6.11
PEG (NY)0.54
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.21%
ROE -150.81%
ROCE 15.9%
ROIC 12.56%
ROICexc 13.08%
ROICexgc 17.82%
OM 21.09%
PM (TTM) N/A
GM 34.69%
FCFM 7.04%
ROA(3y)-4.58%
ROA(5y)-0.24%
ROE(3y)-63.66%
ROE(5y)-29.04%
ROIC(3y)10.65%
ROIC(5y)10.84%
ROICexc(3y)11.07%
ROICexc(5y)11.72%
ROICexgc(3y)17.77%
ROICexgc(5y)19.74%
ROCE(3y)13.49%
ROCE(5y)13.72%
ROICexcg growth 3Y-8.19%
ROICexcg growth 5Y-5.86%
ROICexc growth 3Y-1.67%
ROICexc growth 5Y-0.8%
OM growth 3Y-6.17%
OM growth 5Y-4.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.27%
GM growth 5Y-2.81%
F-Score5
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 5.68
Debt/FCF 14.65
Debt/EBITDA 3.43
Cap/Depr 68.53%
Cap/Sales 5.26%
Interest Coverage 3.43
Cash Conversion 42.77%
Profit Quality N/A
Current Ratio 2
Quick Ratio 1.08
Altman-Z 2.23
F-Score5
WACC8.77%
ROIC/WACC1.43
Cap/Depr(3y)97.35%
Cap/Depr(5y)93.69%
Cap/Sales(3y)6.85%
Cap/Sales(5y)6.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.9%
EPS 3Y-11.81%
EPS 5Y-6.12%
EPS Q2Q%90.38%
EPS Next Y21.23%
EPS Next 2Y18.67%
EPS Next 3Y17.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.64%
Revenue growth 3Y0.36%
Revenue growth 5Y1.7%
Sales Q2Q%-16.5%
Revenue Next Year-5.89%
Revenue Next 2Y-0.73%
Revenue Next 3Y1.23%
Revenue Next 5YN/A
EBIT growth 1Y24.1%
EBIT growth 3Y-5.83%
EBIT growth 5Y-2.78%
EBIT Next Year58.8%
EBIT Next 3Y22.73%
EBIT Next 5YN/A
FCF growth 1Y-38.13%
FCF growth 3Y-35.4%
FCF growth 5Y-20.53%
OCF growth 1Y-43.5%
OCF growth 3Y-24%
OCF growth 5Y-14.15%